These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17348868)

  • 1. Antibody therapy (IVIG): evaluation of the use of genomics and proteomics for the study of immunomodulation therapeutics.
    Sapan CV; Reisner HM; Lundblad RL
    Vox Sang; 2007 Apr; 92(3):197-205. PubMed ID: 17348868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immune globulin use in Canada.
    Hanna K; Poulin-Costello M; Preston M; Maresky N
    Can J Clin Pharmacol; 2003; 10(1):11-6. PubMed ID: 12687032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inpatient paediatric use of intravenous immunoglobulin at an academic medical centre.
    Dashti-Khavidaki S; Khalili H; Farshadi F; Aghamohammadi A; Movahedi M; Hajibabaei M
    Singapore Med J; 2008 Feb; 49(2):147-9. PubMed ID: 18301844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The disease-specific arm of the therapeutic effect of intravenous immunoglobulin in autoimmune diseases: experimental autoimmune myasthenia gravis as a model.
    Fuchs S; Feferman T; Meidler R; Brenner T; Laub O; Souroujon MC
    Isr Med Assoc J; 2008 Jan; 10(1):58-60. PubMed ID: 18300576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does IVIg administration yield improved immune function in very premature neonates?
    Wynn JL; Seed PC; Cotten CM
    J Perinatol; 2010 Oct; 30(10):635-42. PubMed ID: 20054335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin therapy for autoimmune diseases.
    Arnson Y; Shoenfeld Y; Amital H
    Autoimmunity; 2009 Sep; 42(6):553-60. PubMed ID: 19657774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic activities of intravenous immunoglobulins in multiple sclerosis involve modulation of chemokine expression.
    Pigard N; Elovaara I; Kuusisto H; Paalavuo R; Dastidar P; Zimmermann K; Schwarz HP; Reipert B
    J Neuroimmunol; 2009 Apr; 209(1-2):114-20. PubMed ID: 19217671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin suppresses experimental myasthenia gravis: immunological mechanisms.
    Zhu KY; Feferman T; Maiti PK; Souroujon MC; Fuchs S
    J Neuroimmunol; 2006 Jul; 176(1-2):187-97. PubMed ID: 16730380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of intravenous immunoglobulins in clinical practice: data from three French university hospitals.
    Frauger E; Grassi J; Pradel V; Bornet C; Rouby F; Delorme J; Ousset S; Braguer D; Azulay JP; Penot-Ragon C; Harle JR; Bongrand MC; Weiller PJ; Pouget J; Michel G; Micallef J; Reynier JP; Tardieu S; Vanelle P; Blin O;
    Fundam Clin Pharmacol; 2011 Dec; 25(6):753-61. PubMed ID: 21219439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evolution of polyvalent intravenous immunoglobulins (IVIg) prescription, at the Assistance Publique - Hopitaux de Paris between 1988 and 1997. Results of the plan of action set up in order to regulate the prescription].
    Courtay A; Couturon I; Charpentier E; Viens-Bitker C; Guillevin L; Etienne JP; Fery-Lemonnier E
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S5-12. PubMed ID: 10896982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of the effects of intravenous immunoglobulin in human whole blood.
    Ghielmetti M; Bellis M; Spycher MO; Miescher S; Vergères G
    Mol Immunol; 2006 Mar; 43(7):939-49. PubMed ID: 16045989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin and salicylate differentially modulate pathogenic processes leading to vascular damage in a model of Kawasaki disease.
    Lau AC; Duong TT; Ito S; Yeung RS
    Arthritis Rheum; 2009 Jul; 60(7):2131-41. PubMed ID: 19565485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
    Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
    Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
    Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin utilization in a tertiary care teaching hospital in Saudi Arabia.
    Alangari AA; Abutaleb MH; Albarraq AA; Al-Dhowailie AA
    Saudi Med J; 2008 Jul; 29(7):975-9. PubMed ID: 18626524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines on the use of intravenous immune globulin for hematologic conditions.
    Anderson D; Ali K; Blanchette V; Brouwers M; Couban S; Radmoor P; Huebsch L; Hume H; McLeod A; Meyer R; Moltzan C; Nahirniak S; Nantel S; Pineo G; Rock G
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S9-56. PubMed ID: 17397769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulins induce CD32-mediated platelet aggregation in vitro.
    Pollreisz A; Assinger A; Hacker S; Hoetzenecker K; Schmid W; Lang G; Wolfsberger M; Steinlechner B; Bielek E; Lalla E; Klepetko W; Volf I; Ankersmit HJ
    Br J Dermatol; 2008 Sep; 159(3):578-84. PubMed ID: 18565176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intravenous immune globulin in the ICU: a retrospective review of prescribing practices and patient outcomes.
    Foster R; Suri A; Filate W; Hallett D; Meyer J; Ruijs T; Callum JL; Sutton D; Mehta S
    Transfus Med; 2010 Dec; 20(6):403-8. PubMed ID: 20663105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation of anti-Fas antibodies in different lots of intravenous immunoglobulin.
    Reipert BM; Stellamor MT; Poell M; Ilas J; Sasgary M; Reipert S; Zimmermann K; Ehrlich H; Schwarz HP
    Vox Sang; 2008 May; 94(4):334-41. PubMed ID: 18266779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.